Research summary
Probiotics and Mental Health
Interest in the gut-brain axis has driven research into probiotics, sometimes called psychobiotics, as a possible support for mood. Pooled randomized controlled trials suggest a small, statistically significant reduction in anxiety scores with probiotics versus placebo, while a separate meta-analysis in people with depression found no significant pooled effect on depressive symptoms. Across these analyses the evidence is limited by few and short trials and by differences in strains and doses, so the findings remain preliminary and no optimal regimen has been identified.[1], [2]
The gut-brain rationale
The idea behind studying probiotics for mental health rests on the gut-brain axis: communication between the gut microbiome and the central nervous system. Researchers have used the term psychobiotics for live microorganisms that, when consumed, might influence mood-related outcomes through this pathway. This rationale has prompted controlled trials testing whether probiotic supplementation changes symptoms of anxiety and depression, but a plausible mechanism is not the same as a demonstrated clinical effect, and the trial evidence is still being assembled.[1], [2]
What the trials report for anxiety
A 2023 systematic review and meta-analysis pooled 29 randomized controlled trials (2035 participants) of gut-microbiome interventions and found that probiotics significantly reduced anxiety scores compared with placebo. However, the combined effect size was small, and the authors explicitly described the findings as preliminary, noting that it may be premature to conclude clinical efficacy.[1]
The same analysis reported no consensus on the optimal probiotic dose, strain, treatment type, or duration, and stated that the underlying mechanisms remain unclear. This means that even where a signal appears, it is not yet possible to translate it into a specific, evidence-based regimen.[1], [2]
What the trials report for depression
A separate 2023 systematic review and meta-analysis examined probiotic supplementation in patients with depression. Drawing on 4 randomized controlled trials with assessment periods of one to two months, the pooled effect on depressive symptoms was negligible and not statistically significant, even though a moderate improvement was seen for cognitive measures in the same analysis.[2]
Limitations of the evidence
These meta-analyses rest on a small number of trials, often with short intervention durations of only one to two months, and they combine different probiotic strains and doses. The authors themselves frame the results as preliminary and call for more standardized, larger studies. As a result, the current evidence does not establish that probiotics reliably improve anxiety or depressive symptoms, and no optimal product, dose, or duration has been identified.[1], [2]
References
- Effectiveness of probiotic/prebiotic/synbiotic treatments on anxiety: A systematic review and meta-analysis of randomized controlled trials.. Journal of affective disorders. 2023. Systematic review and meta-analysis View source →
- Effect of probiotic supplementation on cognition and depressive symptoms in patients with depression: A systematic review and meta-analysis.. Medicine. 2023. Systematic review and meta-analysis View source →